Legend Biotech Newsroom

CMB International: Maintains INNOVENT BIO's "Buy" rating, with the Target Price raised to 57.67 HKD.

CMB International has released a research report stating that it maintains a "Buy" rating for INNOVENT BIO (01801), being bullish on the global potential of INNOVENT's Innovative Drugs pipeline, and has raised the target price to HKD 57.67 (previous value: HKD 55.21; WACC: 9.5%, perpetual growth rate: 3.5%). The company has licensed the global rights of the new DLL3ADC (IBI3009) to Roche, receiving an upfront payment of USD 80 million and up to USD 1 billion in milestone payments and sales sharing. The drug is expected to receive IND approval for global Phase 1 research in December 2024. Regarding the DLL3 target, besides

Sina Hong Kong StocksJan 3 03:36 ET

Risks Still Elevated At These Prices As Legend Biotech Corporation (NASDAQ:LEGN) Shares Dive 26%

Simply Wall StJan 2 07:34 ET

Karyopharm Tapped Lori Macomber Of Legend Biotech As CFO, Effective January 3

BenzingaJan 2 07:06 ET

Breaking Down Legend Biotech: 9 Analysts Share Their Views

BenzingaDec 30, 2024 13:00 ET

Legend Biotech Analyst Ratings

BenzingaDec 30, 2024 12:19 ET · Ratings

Analysts Offer Insights on Healthcare Companies: Legend Biotech (LEGN) and NewAmsterdam Pharma Company (NAMS)

TipRanksDec 30, 2024 06:40 ET · Ratings

Piper Sandler Maintains Legend Biotech(LEGN.US) With Buy Rating, Cuts Target Price to $78

Moomoo NewsDec 30, 2024 06:31 ET · Ratings

Piper Lowers Sales Estimates for Legend Biotech's Carvykti

TipRanksDec 30, 2024 06:25 ET

Top Midday Decliners

MT NewswiresDec 24, 2024 12:38 ET

Legend Biotech Announces Employee Transition Agreement

TipRanksDec 23, 2024 16:30 ET

Express News | Legend Biotech Corp: Appointment of Jessie Yeung as Interim CFO

ReutersDec 23, 2024 16:29 ET

Express News | Legend Biotech Corp: Resignation of Lori Macomber as CFO- SEC Filing

ReutersDec 23, 2024 16:28 ET

Express News | Legend Biotech Corp : JP Morgan Cuts Target Price to $77 From $80

ReutersDec 23, 2024 00:09 ET

25 U.S. 'Highest Conviction' Stocks – UBS

Seeking AlphaDec 19, 2024 10:48 ET

Legend Biotech to Present at the 43rd Annual J.P. Morgan Healthcare Conference

GlobeNewswireDec 19, 2024 08:01 ET

(LEGN) - Analyzing Legend Biotech's Short Interest

BenzingaDec 16, 2024 14:00 ET

Legend Biotech Management to Meet With Piper Sandler

TipRanksDec 12, 2024 14:20 ET

China to Lift Fiscal Spending to Boost Economy

Dow JonesDec 12, 2024 06:57 ET

China Central Economic Work Conference: A Key Indicator for Future Market Trends

Moomoo News GlobalDec 11, 2024 05:38 ET

BMO Capital Maintains Legend Biotech(LEGN.US) With Buy Rating, Maintains Target Price $90

Moomoo NewsDec 10, 2024 08:31 ET · Ratings